Evidence map›Paper›PMID 39205220›Full record

ArticleViruses2024

Molecular Bases and Specificity behind the Activation of the Immune System OAS/RNAse L Pathway by Viral RNA.

Emma Jung-Rodriguez, Florent Barbault, Emmanuelle Bignon, Antonio Monari

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emma Jung-RodriguezUniversité Paris Cité and CNR, ITODYS, F-75006 Paris, France.
Florent BarbaultUniversité Paris Cité and CNR, ITODYS, F-75006 Paris, France.
Emmanuelle BignonUniversité de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.ORCID 0000-0001-9475-5049
Antonio MonariUniversité Paris Cité and CNR, ITODYS, F-75006 Paris, France.ORCID 0000-0001-9464-1463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first line of defense against invading pathogens usually relies on innate immune systems. In this context, the recognition of exogenous RNA structures is primordial to fight, notably, against RNA viruses. One of the most efficient immune response pathways is based on the sensing of RNA double helical motifs by the oligoadenylate synthase (OAS) proteins, which in turn triggers the activity of RNase L and, thus, cleaves cellular and viral RNA. In this contribution, by using long-range molecular dynamics simulations, complemented with enhanced sampling techniques, we elucidate the structural features leading to the activation of OAS by interaction with a model double-strand RNA oligomer mimicking a viral RNA. We characterize the allosteric regulation induced by the nucleic acid leading to the population of the active form of the protein. Furthermore, we also identify the free energy profile connected to the active vs. inactive conformational transitions in the presence and absence of RNA. Finally, the role of two RNA mutations, identified as able to downregulate OAS activation, in shaping the protein/nucleic acid interface and the conformational landscape of OAS is also analyzed.

Indexed as

2',5'-Oligoadenylate SynthetaseEndoribonucleasesMolecular Dynamics SimulationRNA, ViralAllosteric RegulationHumansImmunity, InnateMutationNucleic Acid ConformationProtein BindingProtein ConformationRNA, Double-StrandedRNA Viruses2-5A-dependent ribonuclease2',5'-Oligoadenylate SynthetaseEndoribonucleasesRNA, Double-StrandedRNA, Viralfree energy profilesinnate immune systemmolecular dynamicsoligoadenylate synthaseRNA viruses

Identifiers

PMID39205220
PMCPMC11359028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.